Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ClariPi Inc. logo — Ultra-Low-Dose AI CT Image Denoising Solution | Fully Automa...

ClariPi Inc.

Ultra-Low-Dose AI CT Image Denoising Solution | Fully Automated AI-Powered 3D Reporting: Emphysema|Covid-19 Pneumonia

Founded 2015 Korea South Korea South 11 employees

General Information

Company Name ClariPi Inc.
Founded Year 2015
Location Korea South Korea South +2
Employees 11
Social

Get notified when ClariPi Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ClariPi Inc.

ClariPi is an AI company that offers innovative medical imaging solutions through deep-learning and AI technology to change the standards of patient safety, making it our number one priority to reduce harmful health risks. Our products help patients get CT scans with radiation dose at virtually harmless level (1/10th of current practice) and yet produces high-quality images for diagnosis.   [Our Key Products] * ClariCT.AI: provides powerful denoising and image clarity enabled by our signature AI-powered clarity engine. This solution works with any CT scanner and PAC system which also can be paired with low-dose and ultra-low-dose CT scans. * ClariPulmo: a fully automated AI-powered 3D reporting solution for emphysema and COVID-19 pneumonia. Our powerful pre-trained deep learning model provides accurate quantitative analysis of lung nodules as well as low-attenuation and high-attenuation lesions despite strong image noise and varying scanning conditions. It is best suited for low-dose lung CT screenings. Ask us how this product can help with COVID-19. * ClariSIGMAM: a fully automated zero-click breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. * ClariOsteo: an AI-powered precision bone healthcare solution with low-dose CT images. It uses existing CT scans and automatically provides analysis reports on spine fractures and osteoporosis risks which is useful for prevention and treatment management.  * ClariACE: an AI-powered augmented contrast enhancing solution for low-dose CECT images. Our powerful pre-trained deep learning model selectively boosts contrast agent components in CT images without increasing contrast agent doses for patients. It clearly and selectively enhances the contrast of iodine without increasing noise in CT images.    Our representative can give you a quick demo of these products as well as detailed image comparisons if you are interested. Thank you!

No funding data available for ClariPi Inc. yet.

Get notified when ClariPi Inc. raises funding

FAQ About ClariPi Inc.

Ultra-Low-Dose AI CT Image Denoising Solution | Fully Automated AI-Powered 3D Reporting: Emphysema|Covid-19 Pneumonia
ClariPi Inc. was founded in 2015.
ClariPi Inc. is headquartered in Korea South.
ClariPi Inc. has approximately 11 employees.

We're actively collecting intelligence on ClariPi Inc..

Track ClariPi Inc. to get notified

Don't just browse. Track.

Signal Tracker monitors ClariPi Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy